Last reviewed: June 27, 2026
Last updated: June 27, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide works by delivering medication through subcutaneous injection—meaning under the skin but above the muscle. Selecting appropriate injection sites and rotating between them helps maximize medication absorption while minimizing injection-site reactions and discomfort.
Approved Semaglutide Injection Sites Explained
The abdomen, thigh, and upper arm are the three FDA-approved sites for semaglutide injection. Each location offers different absorption rates and comfort profiles depending on individual body composition and injection frequency. The abdomen typically absorbs medication fastest, making it reliable for consistent weekly dosing schedules used in weight loss protocols.
Abdominal injections should be placed at least two finger-widths away from the belly button to avoid sensitive tissue around the navel. The outer thigh—from hip to knee on the outer surface—provides a second-choice site with slightly slower absorption, useful when rotating away from the abdomen. The upper arm (back of the triceps area) serves as the third approved location, though many patients find it requires assistance or careful self-injection technique.
Why Rotating Your Injection Sites Prevents Complications
Repeated injections in the same small area can cause lipohypertrophy (fatty tissue buildup) or lipoatrophy (tissue loss), both of which interfere with medication absorption and cause visible lumps or dimples under the skin. Rotating between different body areas ensures even medication distribution and reduces the risk of injection-site reactions that become more common after weeks of repeated injections in identical spots.
A practical rotation strategy involves using the abdomen for weeks one and two, the left thigh for week three, the right thigh for week four, and the upper arm for week five before returning to the abdomen. This five-week cycle gives each injection site adequate healing time while maintaining consistent medication delivery. Patients on PlexusDx semaglutide therapy should document injection sites in a log to track rotation patterns and identify any developing skin changes.
Step-by-Step Guide to Safe Semaglutide Injection Technique
Clean the injection site with an alcohol wipe and allow the skin to air-dry for 30 seconds before injecting—wet skin reduces medication effectiveness and can cause discomfort. Pinch the skin gently to create a small fold, then insert the needle at a 90-degree angle (perpendicular to the skin) unless your prescriber instructs otherwise. Slowly depress the plunger over 3–5 seconds to allow subcutaneous tissue time to accept the full medication volume without bruising.
After injection, withdraw the needle and release the pinched skin gently; do not massage the injection site immediately, as this can cause medication to leak back out or bruising to form. A small amount of bleeding or clear fluid seeping from the puncture is normal and requires only light pressure with a clean gauze pad for 10 seconds. Dispose of all needles in a sharps container and never reuse needles, as dulled tips cause tissue trauma and increase injection discomfort over time.
Managing Injection Site Reactions and Discomfort
Minor redness, swelling, or bruising at the injection site typically resolves within 24–48 hours and does not require treatment beyond ice application if desired. However, persistent pain, increasing swelling, signs of infection (warmth, pus, fever), or hard lumps lasting more than two weeks warrant contact with your healthcare provider. Many patients report that injection discomfort decreases after the first 2–3 weeks as the body adjusts to the medication and injection technique becomes more practiced.
Applying a cold compress for 5 minutes before injection can numb the area and reduce pain perception during needle insertion. Allowing injections to reach room temperature (if refrigerated) before use also decreases injection discomfort compared to cold medication. PlexusDx patients experiencing persistent injection-site concerns should discuss alternative delivery methods—such as oral semaglutide—with their prescriber, as oral formulations avoid injection-site issues entirely while maintaining similar weight-loss effectiveness.
How Individual Factors Affect Your Injection Site Choice
Body composition, skin sensitivity, and personal preference all influence which injection site works best for individual patients. Individuals with higher abdominal body fat may find that location more comfortable because subcutaneous tissue is naturally thicker; conversely, very lean patients sometimes prefer the thigh or upper arm to ensure adequate subcutaneous depth. Some patients report faster or slower weight-loss responses depending on their chosen site, potentially due to variations in absorption rates across body regions.
The Precision Peptide Genetic Test from PlexusDx analyzes individual genetic variants (GIPR rs1800437, GLP1R rs6923761, MC4R rs17782313, and others across 14 metabolic pathways) that influence how each patient's body processes GLP-1 medications. While genetic testing does not directly determine injection site choice, understanding your peptide-pathway predisposition can help your prescriber optimize your overall semaglutide protocol for maximum absorption and weight-loss outcomes. Patients combining site rotation best practices with genetically personalized dosing often report faster and more sustainable results.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I inject semaglutide in areas other than the abdomen, thigh, and upper arm?
No—the abdomen, outer thigh, and upper arm are the only FDA-approved injection sites for semaglutide. Injecting in other areas increases the risk of improper absorption, tissue damage, and medication ineffectiveness. Always follow approved site guidelines provided by your PlexusDx prescriber.
How often should I rotate between injection sites?
A practical approach is to rotate sites weekly or use a five-week cycle (abdomen weeks 1–2, left thigh week 3, right thigh week 4, upper arm week 5) to allow adequate healing time. Rotating prevents lipohypertrophy and ensures consistent medication absorption, which is especially important for maintaining steady weight-loss progress.
What is the cost of PlexusDx compounded semaglutide injections?
PlexusDx compounded semaglutide injection starts at $149 per month across all commitment tiers from licensed 503A compounding pharmacies. Your dose may need to go up during treatment, but your price remains flat. PlexusDx serves all 50 states with no insurance required and offers HSA/FSA eligibility.
Is bleeding or bruising at the injection site normal?
Minor bleeding or light bruising is normal and usually resolves within 24–48 hours with no treatment needed. However, persistent pain, increasing swelling, signs of infection, or hard lumps lasting more than two weeks warrant contact with your healthcare provider to rule out complications.
Can genetic testing help me choose better injection sites or doses?
The PlexusDx Precision Peptide Genetic Test ($99 add-on) analyzes 150+ genetic insights across 14 metabolic pathways to optimize your personalized semaglutide protocol—including ideal dosing based on your GLP1R and GIPR variants. While the test doesn't determine injection site choice directly, understanding your genetic predispositions helps your prescriber fine-tune your entire treatment plan for better outcomes.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What Is the Other Shot Like Ozempic?
Can You Eat Pizza on Zepbound? Navigating Your Weight Loss Journey with Indulgences